InvestorsObserver
Sign Up Login

SHPH Shuttle Pharmaceuticals Holdings

$0.39 $0.00 (-0.26%)
15 Minute Delayed Price Enable Real-Time Price
Add to Watchlist Compare
Overall

SHPH Stock Analysis Overview

What this means: Shuttle Pharmaceuticals Holdings (SHPH) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives SHPH a rank of 10. Our methodology considers analysis of the company's financial situation and how it has traded recently. SHPH rank of 10 means that it ranks below 90% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

SHPH Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

SHPH Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

SHPH Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

SHPH Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

SHPH Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

SHPH Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

SHPH Stock Analysis Overview

What this means: Shuttle Pharmaceuticals Holdings (SHPH) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives SHPH a rank of 10. Our methodology considers analysis of the company's financial situation and how it has traded recently. SHPH rank of 10 means that it ranks below 90% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full SHPH report

SHPH Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

SHPH Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

SHPH Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

SHPH Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

SHPH Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

SHPH Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Shuttle Pharmaceuticals Holdings (SHPH) Analyst Forecast

SHPH Price, Volume, Earnings, and Dividend Date

  • Last Price $0.39
  • Previous Close $0.39
  • Change $0.00
  • Open $0.37
  • Volume 17,911
  • Avg. Volume (100-day) 122,642
  • Market Cap 6,533,213
  • Days Range 0.371 - 0.4299
  • 52-week Range 0.35 - 2.75
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 05/23/24
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Avg. Analyst Rec. Premium
  • Beta 1.100
  • PEG Ratio —

Shuttle Pharmaceuticals Holdings (SHPH) Company Description

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

Shuttle Pharmaceuticals Holdings (SHPH) Stock Chart

View Interactive SHPH chart

My Watchlists

Top Stocks in Drug Manufacturers - Specialty & Generic